Mbt Financial Corp (MBTF) 7.24 $MBTF MBT Financial Corp.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mbt Financial Corp (MBTF) 7.24 $MBTF

MBT Financial Corp. Announces Second Quarter 2016 Preliminary Earnings Release and Conference Call
GlobeNewswire - Mon Jun 20, 7:49AM CDT
MBT Financial Corp. (NASDAQ:MBTF) announced today that it will release its second quarter 2016 preliminary results after the close of the market on Thursday, July 28, 2016. The earnings report will be available on the company's website, www.mbandt.com. The company will also host an investor conference call to review the results on Friday, July 29, 2016 at 10 a.m. Eastern. Participants in the United States are asked to call toll free (877) 510-3783 at least five minutes prior to the call. The toll free number for callers from Canada is (855) 669-9657 and the international number is (412) 902-4136.
MBTF: 7.24 (+0.05)

Shares of MBTF Up 50.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:19AM CDT
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 16 months, MBT Financial has returned 50.60% as of today's recent price of $8.11.
MBTF: 7.24 (+0.05)

Shares of MBTF Up 48.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon May 23, 12:45PM CDT
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 16 months, MBT Financial has returned 48.90% as of today's recent price of $8.02.
MBTF: 7.24 (+0.05)

MBT Financial Has Returned 53.8% Since SmarTrend Recommendation (MBTF)
Comtex SmarTrend(R) - Fri May 13, 12:49PM CDT
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 15 months, MBT Financial has returned 53.76% as of today's recent price of $8.28.
MBTF: 7.24 (+0.05)

MBT Financial Shares Up 66.9% Since SmarTrend's Buy Recommendation (MBTF)
Comtex SmarTrend(R) - Thu Apr 28, 12:52PM CDT
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 15 months, MBT Financial has returned 66.95% as of today's recent price of $8.99.
MBTF: 7.24 (+0.05)

Uptrend Call Working As MBT Financial Stock Rises 47.8% (MBTF)
Comtex SmarTrend(R) - Wed Apr 06, 12:10AM CDT
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 14 months, MBT Financial has returned 47.82% as of today's recent price of $7.96.
MBTF: 7.24 (+0.05)

MBT Financial Up 47.3% Since SmarTrend Uptrend Call (MBTF)
Comtex SmarTrend(R) - Tue Mar 29, 12:45PM CDT
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 14 months, MBT Financial has returned 47.26% as of today's recent price of $7.93.
MBTF: 7.24 (+0.05)

MBT Financial Corp. Announces First Quarter 2016 Preliminary Earnings Release and Conference Call
GlobeNewswire - Mon Mar 28, 3:19PM CDT
MBT Financial Corp. (NASDAQ:MBTF) announced today that it will release its first quarter 2016 preliminary results after the close of the market on Thursday, April 28, 2016. The earnings report will be available on the company's website, www.mbandt.com. The company will also host an investor conference call to review the results on Friday, April 29, 2016 at 10 a.m. Eastern. Participants in the United States are asked to call toll free (877) 510-3783 at least five minutes prior to the call. The toll free number for callers from Canada is (855) 669-9657 and the international number is (412) 902-4136.
MBTF: 7.24 (+0.05)

51.7% Return Seen to Date on SmarTrend MBT Financial Call (MBTF)
Comtex SmarTrend(R) - Thu Mar 03, 6:10PM CST
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 13 months, MBT Financial has returned 51.72% as of today's recent price of $8.17.
MBTF: 7.24 (+0.05)

MBT Financial Shares Up 42.8% Since SmarTrend's Buy Recommendation (MBTF)
Comtex SmarTrend(R) - Wed Feb 10, 4:39PM CST
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 12 months, MBT Financial has returned 42.80% as of today's recent price of $7.69.
MBTF: 7.24 (+0.05)

Monroe Bank & Trust Announces New Duties and Responsibilities for Senior and Executive Officers
GlobeNewswire - Mon Feb 08, 4:00PM CST
Effective immediately, Don Lieto, Executive Vice President & Senior Administration Manager has accepted his new role as Executive Vice President, Continuity and Acquisition Integration Director for Monroe Bank & Trust (MBT). Mr. Lieto will continue to be responsible for the oversight of Deposit Operations, Facilities Management, and Information Technology in addition to his new duties. As Continuity and Acquisition Integration Director, Mr. Lieto will be responsible for the development of a comprehensive acquisition integration play book. Doug Chaffin, President & CEO of MBT commented, "While we have no specific acquisition targets that we are working on today, in light of an ever-changing banking environment in southeast Michigan and northwest Ohio, we need to plan for this eventuality." Mr. Chaffin went on to say that, "Our team at MBT has successfully steered our company clear of all past challenges as noted by our financial performance these past few years. I'm thrilled that Don has accepted this new role, as it allows us to focus more proactively on our strategies for continued growth and profitability."
MBTF: 7.24 (+0.05)

MBT Financial Corp. Announces Dividends and Share Repurchase Authorization
GlobeNewswire - Thu Jan 28, 4:08PM CST
MBT Financial Corp. (NASDAQ:MBTF) announced today that its Board of Directors approved the resumption of regular dividend payments beginning with a $0.03 per share dividend. This is the first dividend paid by the company since 2009. In addition, the Board of Directors also approved payment of a special dividend of $0.50 per share. The two dividend payments will be paid in a single distribution on February 19, 2016 to shareholders of record as of February 12, 2016.
MBTF: 7.24 (+0.05)

32.8% Return Seen to Date on SmarTrend MBT Financial Call (MBTF)
Comtex SmarTrend(R) - Tue Jan 26, 6:13PM CST
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 12 months, MBT Financial has returned 32.78% as of today's recent price of $7.15.
MBTF: 7.24 (+0.05)

MBT posts 4Q profit
Automated Insights - Mon Jan 25, 4:11PM CST
MONROE, Mich. (AP) _ MBT Financial Corp. (MBTF) on Monday reported fourth-quarter earnings of $4 million.
MBTF: 7.24 (+0.05)

MBT Financial Corp. Announces Preliminary Fourth Quarter and Full Year 2015 Profit
GlobeNewswire - Mon Jan 25, 3:57PM CST
MBT Financial Corp., (Nasdaq:MBTF), the parent company of Monroe Bank & Trust, reported a preliminary net profit of $4,014,000 ($0.18 per share, basic and diluted), in the fourth quarter of 2015, compared to a profit of $2,149,000 ($0.09 per share, basic and diluted), in the fourth quarter of 2014. The net profit for the year ended December 31, 2015 was $12,082,000 ($0.53 per share, basic and diluted), compared to $7,315,000 ($0.33 per share, basic and diluted) in the year ended December 31, 2014.
MBTF: 7.24 (+0.05)

MBT Financial Has Returned 32.6% Since SmarTrend Recommendation (MBTF)
Comtex SmarTrend(R) - Tue Jan 12, 12:04PM CST
SmarTrend identified an Uptrend for MBT Financial (NASDAQ:MBTF) on February 6th, 2015 at $5.39. In approximately 11 months, MBT Financial has returned 32.59% as of today's recent price of $7.14.
MBTF: 7.24 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Exro Technologies Reveals Quarterly Progress and Financial Insights

Updated Category News Views 362

Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...

Continue Reading
dsm-firmenich Appoints New Leaders to Propel Future Growth

Updated Category News Views 548

dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...

Continue Reading
Insight Partners Rolls Out $12.5B for Software Innovation Growth

Updated Category News Views 805

Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 123

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Microbiological Testing of Water Market Growth Forecasts

Updated Category News Views 101

The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...

Continue Reading